Labor, Premature
12
0
0
6
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
33.3%
4 terminated out of 12 trials
60.0%
-26.5% vs benchmark
50%
6 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia
Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial
Correlation Between Vitamin D and B Regulatory Cell in Pregnancy
N-acetylcysteine in Intra-amniotic Infection/Inflammation
Magnesium Sulfate Versus Indomethacin for Preterm Labor
Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women
Two Dose Regimens of Nifedipine for the Management of Preterm Labor
Vaginal Progesterone as a Treatment for Women Active Preterm Labor
Nifedipine Compared to Atosiban for Treating Preterm Labor
A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor
Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population
The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor.